Esomeprazole-based 1-week triple therapy directed by susceptibility testing for eradication of Helicobacter pylori infection in children

Journal of Pediatric Gastroenterology and Nutrition

Volumn 43, Issue 2, 2006, Pages 180-184

  Arenz, Tina ^a   Antos, David ^a   Rüssmann, Holger ^b   Alberer, Martin ^a   Buderus, Stefan ^c   Kappler, Matthias ^a   Koletzko, Sibylle ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

13C urea breath test; Antimicrobial resistance; Children; Esomeprazole; Fluorescent in situ hybridization; Helicobacter pylori infection; Intention to treat analysis; Triple therapy

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; ESOMEPRAZOLE; METRONIDAZOLE;

ABDOMINAL PAIN; ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; CHILD; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG INDUCED HEADACHE; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; TASTE DISORDER; UREA BREATH TEST; VOMITING;

ADOLESCENT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BREATH TESTS; CHILD; CHILD, PRESCHOOL; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; OMEPRAZOLE; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

HELICOBACTER PYLORI;

EID: 33746847362     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000228103.89454.a2     Document Type: Article

References (29)

1. Gold B, Colletti RB, Abbott M, et al. Medical position paper: the North American Society for Pediatric Gastroenterology and Nutrition: Helicobacter pylori infection in children: Recommendations for diagnosis and treatment. J Pediatr Gastroenterol Nutr 2000;31:490-7.
2. Kalach N, Benhamou PH, Campeotto F, et al. Clarithromycin resistance and bacterial eradication of Helicobacter pylori in children. Antimicrob Agents Chemother 2001;45:2134-5.
3. Fischer A, Feydt-Schmidt A, Jesch I, et al. Success of first triple therapy in children treated "blindly" and following results of antibiogram [abstract]. Gut 2001;49(suppl 11):A75.
4. Megraud F. Resistance of Helicobacter pylori to antibiotics and its impact on treatment options. Drug Resist Updat 2001;4(3):178-86.
5. McMahon BJ, Hennessy TW, Bensler B, et al. The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections. Ann Intern Med 2003;139:463-9.
6. Megraud F, Lehn N, Lind T, et al. Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother 1999;43(11):2747-52.
7. Dupont C, Kalach N, Raymond J. Helicobacter pylori and antimicrobial susceptibility in children. J Pediatr Gastroenterol Nutr 2003;36(3):311-3.
8. Koletzko S, Antos D, Richy F, et al. On behalf of the European Paediatric Task Force on Helicobacter pylori. Prospective multicenter study from 1999 to 2002 on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe. Gut published online April 7, 2006 (in press).
9. Bontems P, Devaster JM, Corvaglia L, et al. Twelve year observation of primary and secondary antibiotic-resistant Helicobacter pylori strains in children. Pediatr Infect Dis J 2001;20(11):1033-8.
10. Crone J, Granditsch G, Huber WD, et al. Helicobacter pylori in children and adolescents: increase of primary clarithromycin resistance, 1997-2000. J Pediatr Gastroenterol Nutr 2003;36(3): 368-71.
11. Tolia V, Brown W, El-Baba M, et al. Helicobacter pylori culture and antimicrobial susceptibility from pediatric patients in Michigan. Pediatr Infect Dis J 2000;19(12):1167-71.
12. Shashidhar H, Peters J, Lin CH, et al. A prospective trial of lansoprazole triple therapy for pediatric Helicobacter pylori infection. J Pediatr Gastroenterol Nutr 2000;30(3):276-82.
13. Elitsur Y, Rüssmann H, Lawrence Z, et al. High rate of clarithromycin resistance of Helicobacter pylori infected children living in West Virginia. J Pediatr Gastroenterol Nutr 2006;42: 327-8.
14. Miehlke S, Schneider-Brachert W, Bastlein E, et al. Esomeprazole-based one-week triple therapy with clarithromycin and metronidazole is effective in eradicating Helicobacter pylori in the absence of antimicrobial resistance. Aliment Pharmacol Ther 2003;18(8):799-804.
15. Wilder-Smith CH, Rohss K, Nilsson-Pieschl C, et al. Esomeprazole 40 mg provides improved intragastric acid control as compared with lansoprazole 30 mg and rabeprazole 20 mg in healthy volunteers. Digestion 2003;68(4):184-8.
16. Hassall E, Israel DM, Shepherd NA, et al. Omeprazole for healing of severe erosive esophagitis in children. J Pediatr Gastroenterol Nutr 1998;26:547.
17. Drumm B, Koletzko S, Oderda G. Helicobacter pylori infection in children: a consensus statement. J Pediatr Gastroenterol Nutr 2000;30:207-13.
18. Rüssmann H, Adler K, Haas R, et al. Rapid and accurate determination of genotypic clarithromycin resistance in cultured Helicobacter pylori by fluorescent in situ hybridization. J Clin Microbiol 2001;39(11):4142-4.
19. Feydt-Schmidt A, Russmann H, Lehn N, et al. Fluorescence in situ hybridization vs. epsilometer test for detection of clarithromycin-susceptible and clarithromycin-resistant Helicobacter pylori strains in gastric biopsies from children. Aliment Pharmacol Ther 2002;16(12):2073-9.
20. 13C-urea breath test results in children. J Pediatr Gastroenterol Nutr 2000;30:85-91.
21. Peitz U, Sulliga M, Wolle K, et al. High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study. Aliment Pharmacol Ther 2002;16(2):315-24.
22. Feydt-Schmidt A, Kindermann A, Konstantopoulos N, et al. Reinfection rate in children after successful Helicobacter pylori eradication. Eur J Gastroenterol Hepatol 2002;14(10):1119-23.
23. Khurana R, Fischbach L, Chiba N, et al. An update on anti-Helicobacter pylori treatment in children. Can J Gastroenterol 2005;19(7):441-5.
24. Toracchio S, Cellini L, Di Campli E, et al. Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. Aliment Pharmacol Ther 2000;14(12):1639-43.
25. Street ME, Caruana P, Caffarelli C, et al. Antibiotic resistance and antibiotic sensitivity based treatment in Helicobacter pylori infection: advantages and outcome. Arch Dis Child 2001;84(5): 419-22.
26. Lind T, Veldhuyzen VZ, Unge P, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. Helicobacter 1996;1(3):138-44.
27. Gottrand F, Kalach N, Spyckerelle C, et al. Omeprazole combined with amoxicillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis: a prospective randomized double-blind trial. J Pediatr 2001;139(5):664-8.
28. Miehlke S, Mannes GA, Lehn N, et al. An increasing dose of omeprazole combined with amoxicillin cures Helicobacter pylori infection more effectively. Aliment Pharmacol Ther 1997;11(2):323-9.
29. Ford A, Moayyedi P. How can the current strategies for Helicobacter pylori eradication therapy be improved? Can J Gastroenterol 2003;17(suppl B):36B-40B.